ATRC
14.2.2024 16:13:28 CET | Business Wire | Press release
Abu Dhabi’s Advanced Technology Research Council (ATRC) signed a Memorandum of Understanding (MoU) with the Ministry of Information and Telecommunications of the Republic of Serbia, and the Institute for Artificial Intelligence Research and Development of Serbia. This landmark collaboration aims to leverage the technical expertise of ATRC and its subsidiaries for integration of Artificial Intelligence (AI) into Serbia’s technological infrastructure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240214719869/en/
His Excellency Shahab Issa Abu Shahab, Director General of ATRC, Mihailo Jovanović, Minister of Information and Telecommunications of the Republic of Serbia and Dubravko Culibrk, Director of the Institute for AI Research and Development of Serbia signed a Memorandum of Understanding on the sidelines of the World Government Summit 2024. (Photo: AETOSWire)
Under the terms of the MoU, Serbia will support the adoption of the ATRC’s Falcon large language models (LLM) and explore avenues of collaboration with ATRC around Falcon-powered solutions. Furthermore, both entities will work together to encourage organizations from Serbia to join the Falcon Foundation and contribute to the success of open-source Falcon models.
The MoU was signed by His Excellency Shahab Issa Abu Shahab, Director General of ATRC, Mihailo Jovanovic, Minister of Information and Telecommunications of the Republic of Serbia, and Dubravko Culibrk, Director of the Institute for AI Research and Development of Serbia, on the sidelines of the World Governments Summit 2024.
Expressing optimism about the alliance, His Excellency Shahab Issa Abu Shahab, Director General of ATRC said: “AI is a powerful catalyst for innovation and progress. The collaboration between ATRC, the Serbian Ministry of IT, and its Institute of AI Research and Development, marks a critical milestone as we witness an increasing global interest in adopting Falcon. Our shared commitment to the Falcon open-source models ensures a dynamic and inclusive approach to advancing AI capabilities worldwide.”
For his part, Mihailo Jovanović, Minister of Information and Telecommunications of the Republic of Serbia said, “We are taking a step further and thanks to the expertise of the Advanced Technology Research Council (ATRC), we are starting to use and apply Falcon open source models for the development of AI in Serbia. This step forward will help us in further implementation of modernization projects within the Serbia 2027 Programme and strengthen the position of Serbia as a technological and digital leader in the region of Southeast Europe.”
Dubravko Culibrk, Director of the Institute for AI Research and Development of Serbia, also remarked: “We are thrilled to embark on this transformative journey with ATRC. By integrating Falcon open-source models across the board, we aim to drive breakthroughs in AI research and development. Partnerships with governments worldwide are crucial for creating an environment where innovation flourishes, ensuring that AI becomes a driving force for positive change.”
The Falcon LLMs are a family of powerful, open-source large language models developed by the Technology Innovation Institute, ATRC’s applied research arm.
The partnership marks a significant stride in exporting Falcon’s capability at a country level beyond the Middle East, laying the groundwork for global collaborative initiatives that will shape the future of technological innovation.
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240214719869/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom